India Researchers To Test For Local Sources Of Key Tamiflu Ingredient
This article was originally published in PharmAsia News
Executive Summary
Indian scientists believe they are on the threshold of local development of the primary primary ingredient in Roche's Tamiflu (oseltamivir), so far the main treatment for the H1N1 influenza virus. Tamiflu is still under patent protection, so the rest of the ingredients are not public, but shikimic acid taken from the fruit of China's anise tree, is known to be the main one. Indian researchers are searching for local sources of the acid and are setting up commercial trials to determine how much can be extracted from certain Indian trees, and whether there is enough to process in large quantities. (Click here for more
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.